By targeting SPRY1 protein, miR-21 leads to an increased expression of the mitogen-activated protein kinase (MAPK), which results in myocardial fibrosis and cardiac remodeling [42]. The gene discussed is SPRY1; the disease is Myocardial fibrosis.